• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性新生血管性年龄相关性黄斑变性中视网膜色素上皮下间隙的高级定量分析

Advanced quantitative analysis of the sub-retinal pigment epithelial space in recurrent neovascular age-related macular degeneration.

作者信息

Sasaki Mariko, Kato Yu, Fujinami Kaoru, Hirakata Toshiaki, Tsunoda Kazushige, Watanabe Ken, Akiyama Kunihiko, Noda Toru

机构信息

Department of Ophthalmology, National Institute of Sensory Organs, National Tokyo Medical Center, Tokyo, Japan.

Department of Ophthalmology, Tachikawa Hospital, Tokyo, Japan.

出版信息

PLoS One. 2017 Nov 2;12(11):e0186955. doi: 10.1371/journal.pone.0186955. eCollection 2017.

DOI:10.1371/journal.pone.0186955
PMID:29095879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5667874/
Abstract

To quantitatively evaluate changes in the sub-retinal pigment epithelial (RPE) space and determine the association with recurrent neovascular age-related macular degeneration (AMD). Twenty-two eyes treated with intravitreal aflibercept for treatment-naïve neovascular AMD were studied retrospectively. The sub-RPE area, volume, and central retinal thickness (CRT) were evaluated 1 and 2 months after the loading phase using spectral-domain optical coherence tomography. Recurrence was defined as newly detected neovascular activity during the 6 months after the loading phase. In eyes with recurrent AMD, the sub-RPE area increased significantly (P = 0.036) from 1 to 2 months after the loading phase and the sub-RPE volume increased marginally (P = 0.06). Subgroup analysis showed significant (P = 0.008 and P = 0.016, respectively) increases in the sub-RPE area and volume in typical AMD. In eyes with no recurrence, no significant changes occurred in the two parameters. No significant CRT changes occurred in eyes with or without a recurrence. A quantitative analysis demonstrated an increased likelihood of the sub-RPE space shortly after the loading phase in eyes with recurrent AMD; no changes occurred in eyes without a recurrence. These early changes in the sub-RPE space could indicate disease activity and are valuable for predicting recurrences of neovascular AMD.

摘要

为了定量评估视网膜色素上皮(RPE)下间隙的变化,并确定其与复发性新生血管性年龄相关性黄斑变性(AMD)的关联。对22只初治新生血管性AMD患者接受玻璃体内阿柏西普治疗的眼睛进行回顾性研究。在负荷期后1个月和2个月,使用光谱域光学相干断层扫描评估RPE下面积、体积和中央视网膜厚度(CRT)。复发定义为负荷期后6个月内新检测到的新生血管活动。在复发性AMD患者的眼睛中,负荷期后1至2个月RPE下面积显著增加(P = 0.036),RPE下体积略有增加(P = 0.06)。亚组分析显示,典型AMD患者的RPE下面积和体积显著增加(分别为P = 0.008和P = 0.016)。在无复发的眼睛中,这两个参数无显著变化。有或无复发的眼睛中CRT均无显著变化。定量分析表明,复发性AMD患者的眼睛在负荷期后不久RPE下间隙增加的可能性增大;无复发的眼睛无变化。RPE下间隙的这些早期变化可能表明疾病活动,对预测新生血管性AMD的复发具有重要价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64b/5667874/ebb9f9d2976f/pone.0186955.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64b/5667874/832a0b276782/pone.0186955.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64b/5667874/44f67babbd6c/pone.0186955.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64b/5667874/9f43640c776b/pone.0186955.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64b/5667874/ebb9f9d2976f/pone.0186955.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64b/5667874/832a0b276782/pone.0186955.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64b/5667874/44f67babbd6c/pone.0186955.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64b/5667874/9f43640c776b/pone.0186955.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64b/5667874/ebb9f9d2976f/pone.0186955.g004.jpg

相似文献

1
Advanced quantitative analysis of the sub-retinal pigment epithelial space in recurrent neovascular age-related macular degeneration.复发性新生血管性年龄相关性黄斑变性中视网膜色素上皮下间隙的高级定量分析
PLoS One. 2017 Nov 2;12(11):e0186955. doi: 10.1371/journal.pone.0186955. eCollection 2017.
2
Exacerbation of choroidal and retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.抗血管内皮生长因子治疗新生血管性年龄相关性黄斑变性后脉络膜和视网膜色素上皮萎缩加重
Retina. 2014 Jul;34(7):1308-15. doi: 10.1097/IAE.0000000000000081.
3
Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography.频域光相干断层扫描揭示玻璃体内抗血管内皮生长因子治疗后视网膜色素上皮撕裂的形成机制。
Am J Ophthalmol. 2013 Nov;156(5):981-988.e2. doi: 10.1016/j.ajo.2013.06.024. Epub 2013 Aug 20.
4
Progression of retinal pigment epithelial atrophy in antiangiogenic therapy of neovascular age-related macular degeneration.新生血管性年龄相关性黄斑变性抗血管生成治疗中视网膜色素上皮萎缩的进展
Am J Ophthalmol. 2015 Jun;159(6):1100-1114.e1. doi: 10.1016/j.ajo.2015.02.020. Epub 2015 Mar 10.
5
The Onion Sign in Neovascular Age-Related Macular Degeneration Represents Cholesterol Crystals.新生血管性年龄相关性黄斑变性中的洋葱征代表胆固醇结晶。
Ophthalmology. 2015 Nov;122(11):2316-26. doi: 10.1016/j.ophtha.2015.07.008. Epub 2015 Aug 19.
6
DOUBLE RETINAL PIGMENT EPITHELIUM TEARS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.新生血管性年龄相关性黄斑变性中的双视网膜色素上皮撕裂
Retina. 2016 Nov;36(11):2197-2204. doi: 10.1097/IAE.0000000000001062.
7
A hyporeflective space between hyperreflective materials in pigment epithelial detachment and Bruch's membrane in neovascular age-related macular degeneration.在新生血管性年龄相关性黄斑变性中,色素上皮脱离处的高反射材料与布鲁赫膜之间的低反射间隙。
BMC Ophthalmol. 2014 Dec 16;14:159. doi: 10.1186/1471-2415-14-159.
8
RETINAL PIGMENT EPITHELIAL TEAR AFTER INTRAVITREAL RANIBIZUMAB TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.玻璃体腔内注射雷珠单抗治疗新生血管性年龄相关性黄斑变性后视网膜色素上皮撕裂
Retina. 2016 Oct;36(10):1851-9. doi: 10.1097/IAE.0000000000001009.
9
Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration.新生血管性年龄相关性黄斑变性玻璃体内注射雷珠单抗后视网膜色素上皮撕裂的发生率。
Ophthalmology. 2011 Dec;118(12):2447-52. doi: 10.1016/j.ophtha.2011.05.026. Epub 2011 Aug 27.
10
RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.视网膜色素上皮撕裂与抗血管内皮生长因子疗法治疗渗出性年龄相关性黄斑变性:临床病程与长期预后
Retina. 2016 May;36(5):868-74. doi: 10.1097/IAE.0000000000000823.

引用本文的文献

1
Longitudinal Assessment of Ellipsoid Zone Integrity, Subretinal Hyperreflective Material, and Subretinal Pigment Epithelium Disease in Neovascular Age-Related Macular Degeneration.特发性脉络膜新生血管性年龄相关性黄斑变性中椭圆体带完整性、视网膜下高反射物质和视网膜色素上皮病的纵向评估。
Ophthalmol Retina. 2021 Dec;5(12):1204-1213. doi: 10.1016/j.oret.2021.02.012. Epub 2021 Feb 26.
2
Intravitreal injection of the synthetic peptide LyeTx I b, derived from a spider toxin, into the rabbit eye is safe and prevents neovascularization in a chorio-allantoic membrane model.将源自蜘蛛毒素的合成肽LyeTx I b玻璃体内注射到兔眼中是安全的,并且在绒毛尿囊膜模型中可预防新生血管形成。
J Venom Anim Toxins Incl Trop Dis. 2018 Nov 21;24:31. doi: 10.1186/s40409-018-0168-5. eCollection 2018.

本文引用的文献

1
Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration: TREX-AMD 1-Year Results.抗 VEGF 治疗方案的选择:按需治疗与每月治疗对新生血管性年龄相关性黄斑变性的疗效比较:TREX-AMD 研究 1 年结果。
Ophthalmology. 2015 Dec;122(12):2514-22. doi: 10.1016/j.ophtha.2015.08.009. Epub 2015 Sep 29.
2
A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration.在新生血管性年龄相关性黄斑变性的影像学生物标志物方面的范式转变。
Prog Retin Eye Res. 2016 Jan;50:1-24. doi: 10.1016/j.preteyeres.2015.07.007. Epub 2015 Aug 22.
3
Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.
色素上皮脱离,随后发生视网膜囊样变性,导致治疗新生血管性年龄相关性黄斑变性导致视力丧失。
Ophthalmology. 2015 Apr;122(4):822-32. doi: 10.1016/j.ophtha.2014.11.017. Epub 2015 Jan 9.
4
Treatment outcomes after 3 years in neovascular age-related macular degeneration using a treat-and-extend regimen.采用治疗并延长方案治疗3年后新生血管性年龄相关性黄斑变性的治疗结果。
Am J Ophthalmol. 2015 Jan;159(1):3-8.e1. doi: 10.1016/j.ajo.2014.09.011. Epub 2014 Sep 8.
5
Quantitative changes in retinal pigment epithelial detachments as a predictor for retreatment with anti-VEGF therapy.视网膜色素上皮脱离的定量变化可作为抗血管内皮生长因子治疗再治疗的预测指标。
Retina. 2013 Mar;33(3):459-66. doi: 10.1097/IAE.0b013e31827d2657.
6
Impact of availability of anti-vascular endothelial growth factor therapy on visual impairment and blindness due to neovascular age-related macular degeneration.抗血管内皮生长因子疗法的可及性对新生血管性年龄相关性黄斑变性所致视力损害和失明的影响。
Arch Ophthalmol. 2012 Jun;130(6):794-5. doi: 10.1001/archophthalmol.2011.2480.
7
Age-related macular degeneration.年龄相关性黄斑变性。
Lancet. 2012 May 5;379(9827):1728-38. doi: 10.1016/S0140-6736(12)60282-7.
8
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.雷珠单抗和贝伐单抗治疗新生血管性年龄相关性黄斑变性:两年结果。
Ophthalmology. 2012 Jul;119(7):1388-98. doi: 10.1016/j.ophtha.2012.03.053. Epub 2012 May 1.
9
Ranibizumab and bevacizumab for neovascular age-related macular degeneration.雷珠单抗和贝伐单抗治疗新生血管性年龄相关性黄斑变性。
N Engl J Med. 2011 May 19;364(20):1897-908. doi: 10.1056/NEJMoa1102673. Epub 2011 Apr 28.
10
Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study.雷珠单抗灵活给药方案治疗新生血管性年龄相关性黄斑变性的安全性和有效性:SUSTAIN 研究。
Ophthalmology. 2011 Apr;118(4):663-71. doi: 10.1016/j.ophtha.2010.12.019.